CaffarelMaria M. Biogipuzkoa Health Research InstituteSpain

Cancer Researchers to watch - An early career showcase

Time Session
14:00
15:40
(Separate pre-registration required)
BaggioliniArianna Chair Switzerland
  • Welcome Message
    CaffarelMaria M. Chair Spain
  • FAK Inhibition Promotes Critical Cytotoxic Interactions Between CD8 T Cells and Cancer Cells in Metastatic Breast Cancer
    BarthNicole Speaker United Kingdom
  • Proffered Paper 1: Inhibition of Furin in CAR macrophages directs them toward a proinflammatory phenotype and enhances their antitumor activities
    ZIANE CHAOUCHE Lydia Presenter France
  • Proffered Paper 2: Multimodal analysis of spatial transcriptomics data uncovers novel invasive lobular carcinoma subtypes
    SerraMatteo Presenter Belgium
  • Targeting cytokine signalling to block cancer-promoting inflammation and tumour progression
    CaffarelMaria M. Speaker Spain
Auditorium VIII

Monday, 16 June 2025

Time Session
08:30
10:00
(Separate pre-registration required)
CaffarelMaria M. Chair Spain
  • Exploiting metabolic vulnerabilities to improve breast cancer therapy
    MorandiAndrea Speaker Italy
  • Proffered Paper 5: Melting the Iceberg: Nanomedicines Overcoming Stromal Barriers and Recruiting Effector T Cells in Pancreatic Cancer
    AcúrcioCRita Presenter Portugal
  • Proffered Paper 6: ENO3PEP vaccine enhances chemotherapy efficacy in pancreatic cancer by boosting anti-tumor immunity
    BrugiapagliaSilvia Presenter Italy
  • Stem cells-based models of tumor initiation and metastasis
    BaggioliniArianna Speaker Switzerland
  • Refreshment Break
Auditorium VIII

Wednesday, 18 June 2025

Time Session
09:20
10:55
WestermarckJukka Co-Chair Finland
CaffarelMaria M. Co-Chair Spain
  • Drugging transcription factors: HSF1 and Brachyury
    WorkmanPaul Speaker United Kingdom
  • Proffered Paper: Inhibition of WEE1 kinase activity to overcome secondary resistance to targeted therapies in colorectal cancer
    EACR25-0376
    EACR25-0376
    ArenaSabrina Presenter Italy
  • Targeting chromatin proteins for therapeutic benefit in haematological malignancy
    SomervailleTim Speaker United Kingdom
  • Proffered Paper: Reversing Acidic Immune Suppression in Cancer with PTT-4256, A First-In-Class Small Molecule Inhibitor of GPR65
    EACR25-0553
    EACR25-0553
    CorbinAlastair Presenter United Kingdom
  • PP2A inhibitor protein CIP2A is a prime target for TNBC therapy
    WestermarckJukka Speaker Finland
Auditorium I